Our Team

Brad Niles, PhD

Chief Executive Officer

20 years experience in cancer research and product development

Glenn Kazo

Chief Business Officer

Founder of Enzon, inventor of Pegylation technology. Had a leading role in 3 IPOs and raised over $500M

Lonnie Bookbinder, PhD, MBA

Board Chairman

Leadership in pharma industry, drug licensing to pharma, serial entrepreneur, 47 years in industry

Narendra Vaish, PhD

Scientific Advisor

Expert in RNA Inhibition and siRNA drug design with >100 biomed patent applications

Sundeep Dugar, PhD

Scientific Advisor

>30 years in drug development (Scios, J&J, BMS, Schering- Plough, Sphaera Pharma, Epirium Bio, Aayam Therapeutics)

Rupesh Chaturvedi, PhD

Scientific Advisor

Immunology and Cancer researcher, Professor at Jawaharlal Nehru University, India

Shi Huang, PhD

Scientific Advisor

Discoverer or PRDM family, Professor at Central South University, China

Lokesh Sikaria

Board Member

Founder and Managing Director at Moneta Ventures

Kevin Nagle

Board Member

Investor, co-Founder of EnvisionRx Options, former Upjohn executive, co-Owner of Sacramento Kings (NBA) and Sac Republic FC (MLS)

Dr. Manish Bhandari

Board Member

Managing Partner, Angel Physicians Fund

Contact Us